IDXX Q4 2017 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$47B

Q4 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$506M+14.2% YoY

Gross Profit

$272M53.8% margin

Operating Income

$98M19.3% margin

Net Income

$38M7.6% margin

EPS (Diluted)

$0.43

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$121M

Free Cash Flow

$99M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.8B

Stockholders' Equity

-$54M

Cash & Equivalents

$188M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$506M	$443M	+14.2%
Gross Profit	$272M	$241M	+13.2%
Operating Income	$98M	$84M	+16.7%
Net Income	$38M	$52M	-26.9%